Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study

P896

  • Müller-Beienhirtz, H.
  • Kasper, C.
  • Nückel, H.
  • Dührsen, U.

  • Essen, D

Onkologie 26:p 181, October 2003.
Copyright © 2003 S. Karger AG, Basel